Literature DB >> 12004069

Thioredoxin reductase is essential for the survival of Plasmodium falciparum erythrocytic stages.

Zita Krnajski1, Tim-Wolf Gilberger, Rolf D Walter, Alan F Cowman, Sylke Müller.   

Abstract

The human malaria parasite Plasmodium falciparum poses an increasing threat to human health in the tropical regions of the world, and the validation and assessment of possible drug targets is required for the development of new antimalarials. It has been shown that the erythrocytic stages of the parasites, which are responsible for the pathology of the disease in humans, are under enhanced oxidative stress and are particularly vulnerable to exogenous challenges by reactive oxygen species. Therefore it is postulated that the disruption of the antioxidant and/or redox systems of the parasite is a feasible way to interfere with their development during erythrocytic schizogony. In order to test this suggestion thioredoxin reductase (TrxR), an enzyme heavily involved in maintenance of redox homeostasis and antioxidant defense, was knocked out in P. falciparum. It was impossible to generate parasites with a disrupted trxR gene suggesting that TrxR is essential for P. falciparum erythrocytic stages. Technical problems were excluded by transfecting a 3' replacement construct, which recombined correctly and transfectants did not show any phenotypic alterations. In order to prove that the trxR knockout was responsible for the lethal phenotype of the null mutants, a co-transfection with both the knockout construct and a construct containing the trxR coding region under the control of the calmodulin promoter was conducted. Despite the disruption of the trxR gene, parasites were viable. In a Southern blot analysis a complicated restriction pattern was obtained, but it was shown by pulse field gel electrophoresis and field inverse gel electrophoreses that only the trxR gene locus on chromosome 9 was targeted by the constructs. It was found that the co-transfected constructs form concatemeric structures prior to integration into the trxR gene locus, which is further supported by plasmid rescue followed by restriction analyses of the plasmids. Northern and Western blot analyses proved that the co-transfectants highly overexpress TrxR from the introduced gene. Our results demonstrate that TrxR is essential for the survival of the erythrocytic stages of P. falciparum.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12004069     DOI: 10.1074/jbc.M203539200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Degrees of chloroquine resistance in Plasmodium - is the redox system involved?

Authors:  Adele M Lehane; Christopher A McDevitt; Kiaran Kirk; David A Fidock
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-12-01       Impact factor: 4.077

2.  Eosin B as a novel antimalarial agent for drug-resistant Plasmodium falciparum.

Authors:  Kristen M Massimine; Michael T McIntosh; Lanxuan T Doan; Chloé E Atreya; Stephan Gromer; Worachart Sirawaraporn; David A Elliott; Keith A Joiner; R Heiner Schirmer; Karen S Anderson
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

3.  Identification of a thioredoxin reductase from Babesia microti during mammalian infection.

Authors:  Shaoruo Zhao; Haiyan Gong; Yongzhi Zhou; Houshuang Zhang; Jie Cao; Jinlin Zhou
Journal:  Parasitol Res       Date:  2016-05-11       Impact factor: 2.289

4.  Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds.

Authors:  Gregory J Crowther; Alberto J Napuli; James H Gilligan; Kerstin Gagaring; Rachel Borboa; Carolyn Francek; Zhong Chen; Eleanor F Dagostino; Justin B Stockmyer; Yu Wang; Philip P Rodenbough; Lisa J Castaneda; David J Leibly; Janhavi Bhandari; Michael H Gelb; Achim Brinker; Ingo H Engels; Jennifer Taylor; Arnab K Chatterjee; Pascal Fantauzzi; Richard J Glynne; Wesley C Van Voorhis; Kelli L Kuhen
Journal:  Mol Biochem Parasitol       Date:  2010-09-15       Impact factor: 1.759

5.  Glutathione reductase and thioredoxin reductase: novel antioxidant enzymes from Plasmodium berghei.

Authors:  Gaurav Kapoor; Harjeet Singh Banyal
Journal:  Korean J Parasitol       Date:  2009-12-01       Impact factor: 1.341

6.  Computational analysis of Plasmodium falciparum metabolism: organizing genomic information to facilitate drug discovery.

Authors:  Iwei Yeh; Theodor Hanekamp; Sophia Tsoka; Peter D Karp; Russ B Altman
Journal:  Genome Res       Date:  2004-04-12       Impact factor: 9.043

7.  Chemical genetics of Plasmodium falciparum.

Authors:  W Armand Guiguemde; Anang A Shelat; David Bouck; Sandra Duffy; Gregory J Crowther; Paul H Davis; David C Smithson; Michele Connelly; Julie Clark; Fangyi Zhu; María B Jiménez-Díaz; María S Martinez; Emily B Wilson; Abhai K Tripathi; Jiri Gut; Elizabeth R Sharlow; Ian Bathurst; Farah El Mazouni; Joseph W Fowble; Isaac Forquer; Paula L McGinley; Steve Castro; Iñigo Angulo-Barturen; Santiago Ferrer; Philip J Rosenthal; Joseph L Derisi; David J Sullivan; John S Lazo; David S Roos; Michael K Riscoe; Margaret A Phillips; Pradipsinh K Rathod; Wesley C Van Voorhis; Vicky M Avery; R Kiplin Guy
Journal:  Nature       Date:  2010-05-20       Impact factor: 49.962

8.  Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis.

Authors:  Carola Huthmacher; Andreas Hoppe; Sascha Bulik; Hermann-Georg Holzhütter
Journal:  BMC Syst Biol       Date:  2010-08-31

9.  Reconstruction and flux-balance analysis of the Plasmodium falciparum metabolic network.

Authors:  Germán Plata; Tzu-Lin Hsiao; Kellen L Olszewski; Manuel Llinás; Dennis Vitkup
Journal:  Mol Syst Biol       Date:  2010-09-07       Impact factor: 11.429

10.  Development of a Novel High-Density [3H]Hypoxanthine Scintillation Proximity Assay To Assess Plasmodium falciparum Growth.

Authors:  Cristina de Cózar; Iván Caballero; Gonzalo Colmenarejo; Laura M Sanz; Emilio Álvarez-Ruiz; Francisco-Javier Gamo; Concepción Cid
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.